Scientific Program

SUNDAY – July 9
9:00-13:00 PRE CONFERENCE SYMPOSIA New WHO STI Treatment Guidelines Program Science How to read a Cochrane Systematic Review of interventions HIV Research perspectives in Latin American women  
    STI surveillance and estimation tools        
13:00-17:00 PRE CONFERENCE SYMPOSIA Partner Round Table on STI strategy – WHO Program Science How to read a Cochrane Systematic Review of interventions    
  ROOM 1: Segóvia I, II & III ROOM 2: Alhambra I ROOM 3: Alhambra II Room 4: Segóvia IV Room 5: El Pardo II Room 6: El Pardo I
  Chairs: Jeanne Marrazzo & Mauro Romero Leal Passos         POLICY
6:15-7:00 KEYNOTE LECTURE: HIV, STIs and evolution in global health. Kevin M. De Cock, US Centers for Disease Control and Prevention, Kenya (45′)          
MONDAY – July 10
7:00 – 8:30     ASTDA Breakfast session: Connecting human and sexual rights to STI/HIV prevention      
7:15-8:15 Clinical Case Series
Chairs: Suzanne Garland & Somesh Gupta
  Reminder of the Great Imitator, Bradley Stoner          
  Pulmonary Rhodococcus with bacteremia, Marcos Davi Gomes de Sousa (scholarship recipient)          
  Chairs: David Lewis & Charlotte Gaydos          
8:30-9:15 PLENARY 1 and 2nd IUSTI Prestigious Lecture: Update on vaginal microbiome research. Jeanne Marrazzo, University of Alabama at Birmingham School of Medicine, USA (40′)          
9:15-9:45 PLENARY 2: Implications of implementation of PrEP. Sinead Delany-Moretlwe, University of Witwatersrand, South Africa (30′)          
9:45-10:15 PLENARY 3: Maternal-to-child syphilis transmission/elimination in Latin America. Suzanne Serruya, Centro Latino-Americano de Perinatologia (CLAP), Pan American Health Organization, Uruguay (30′)          
10:15-10:30 Morning plenary question period          
10:30-11:15 COFFEE BREAK          
11:15-12:30 SYMPOSIUM 1: New technologies for diagnosis, characterization and control of STIs/HIV Chairs: Barbara Van Der Pol & Roberto Carvalho da Silva SYMPOSIUM 2: Mathematical modeling and decision making in the world of STIs Chairs: Marc Steben & Anne Rompalo SYMPOSIUM 3: Latest generation point-of-care tests for STIs/HIV – a marriage of innovation and technology Chairs: Francis Ndowa & Arlene Sena-Soberano ORAL PRESENTATION SESSION 1 STI surveillance Chairs: Magnus Unemo & Sylvia Bruisten ORAL PRESENTATION SESSION 2 Sexual behavior in men who have sex with men Chairs: Remco Peters & Catriona Ooi ORAL PRESENTATION SESSION 3 STI prevention/diagnosis and community engagement Chairs: Ari Poder & David Hawkins
  Characterizing HIV mucosal transmission through identifying the early foci of viral infection 48 hours after exposure. Thomas Hope, Northwestern University, USA (20′) Use of modelling for evaluation of HIV/STI interventions. Michel Alary, Université Laval, Canada (20′) STI broad spectrum POC or self testing in advanced settings. Tariq Sadiq, St. George’s University of London, UK (20′) TALK 1: A tale of two halves; low extended-spectrum cephalosporin and high azithromycin resistance in Neisseria gonorrhoeae in Europe, 2015. Michelle Cole (10′) TALK 1: Dimensionality of stigma and associated attitudes towards anticipated partner notification among MSM in Lima, Peru: An exploratory factor analysis. Amaya Perez-Brumer (10′) TALK 1: AIDS prevention policy at school in Brazil (1994-2014) and the role of Unesco.  Mariana Braga Neves (10′)
        TALK 2: Predictors of persistent and recurrent genital STI symptoms at sentinel surveillance sites in South Africa, January 2015 – June 2016. Mathebula Rudzani Climentine (10′) TALK 2: Syphilis and sexual geographies: Mapping the sexual travels, networks, and knowledge of gay, bisexual and other men who have sex with men in Toronto, Canada. Dionne Gesink (10′) TALK 2: Understanding sexual health language: community engagement with refugees from Burma, post settlement in Australia.  Amita Tuteja (10′)
  Natural history of HPV-related tumors: key to prevention and therapeutics. Luisa Villa, Universidade de São Paulo, Brazil (20′) The role of mathematical modelling in policy. Nicola Low, University of Bern, Switzerland (20′) Scaling up POC testing and information technology, including HIV self-testing, in low and middle income countries. Rosanna Peeling, London School of Hygiene and Tropical Medicine, UK (20′) TALK 3: High prevalence of Hepatitis C Virus among HIV negative MSM in Amsterdam PrEP project. Roel Achterbergh (10′) TALK 3: Understanding fuckbuddies among men who have sex with men. Eric P.F. Chow (10′) TALK 3: Sex industry regulation, sex worker health and STI/HIV prevention. Victoria Powell (10′)
        TALK 4: Origin and predictors of early repeat infections among HIV negative women with Trichomonas vaginalis receiving a 2 g dose of metronidazole. Patricia Kissinger (10′) TALK 4: It’s just not for me: exploring low prep uptake among young black men who have sex with men in the southern United States. Emily S. Pingel (10′) TALK 4: The role of social science and public patient involvement in the development of novel rapid diagnostic tests for STIs and antimicrobial resistance detection. Sebastian Fuller (10′)
  New technologies for diagnosis and characterization of Chlamydia trachomatis. Angelika Stary, University of Vienna, Austria (20′)     TALK 5: Evaluating Chlamydia trends in the United States 2000-2015 using a pair formation transmission model. Minttu Rönn (10′) TALK 5: Narrating risk: new and traditional methods to understand sexual risk behavior among HIV-uninfected men who have sex with men in Lima, Peru. Jesse L. Clark (10′) TALK5: ISEAN-HIVOS Philippines: strengthening capacities of community-based organizations (CBO) through organizational development (OD) for sustainability of community-led HIV and rights-based interventions. Raine N. Cortes (10′)
    Integrating population genomics and mathematical modeling to control antibiotic resistance in gonococcus. Yonatan Grad,Harvard T.H. Chan School of Public Health, USA (20′) Advancing point of care diagnostics for the control and prevention of sexually transmitted infections: the way forward. Igor Toskin, World Health Organization (20′) TALK 6: Quality assessment of the enhanced gonococcal antimicrobial surveillance program in Thailand, 2015-2016. Emily Weston (10′) TALK 6: Behavioural change to reduce the risk of pharyngeal gonorrhoea in men who have sex with men. Eric P.F. Chow (10′) TALK 6: Syphilis testing practices in the Americas: Results of a regional survey of laboratories. Mary Kamb (10′)
12:30-1:00 Presentation of the Lancet Commission – The current and future challenges in diagnosis and controlling sexually-transmitted infections Introduction: Marco De Ambrogi
Chlamydia control – Jane Hocking
Gonorrhoea – Magnus Unemo
Bacterial Vaginosis – Catriona Bradshaw
STI in low to middle income countries – Rosanna Peeling
STI in MSM – Henry De Vries
Call to Action – Christopher K Fairley
Summary – Nicola Low
12:30-2:00 LUNCH          
12:30-2:00 POSTER VIEWING          
1:00-2:00 IUSTI World General Assembly          
2:00-3:30 SYMPOSIUM 4: The digital age and sexual health: friend or foe? Chairs: Sevgi Aral & Matthew Golden SYMPOSIUM 5: Progress on STI vaccines Chair: Carolyn Deal SYMPOSIUM 6: Policy gaps and opportunities in the elimination of congenital syphilis Chairs: Fabio de Mesquita & Somesh Gupta ORAL PRESENTATION SESSION 4 Women’s health and prevention Chairs: Catriona Bradshaw & William Geisler ORAL PRESENTATION SESSION 5 Neisseria gonorrhoeae Chairs: Keith Radcliffe & Ana Gabriela Travassos ORAL PRESENTATION SESSION 6 Host-pathogen interactions and vaginal/urethral microbiota Chairs: Suzanne Garland & Etienne Muller
  Integrating STI self-testing into an eHealth prevention program for young MSM: The Keep It Up! 2.0 trial. Brian Mustanski, Northwestern University, USA (15′) Progress on a gonorrhea vaccine. Ann Jerse, Uniformed Services University, USA (15′) Achievements and updates in global guidance for EMTCT validation. Melanie Taylor, World Health Organization (15′) TALK 1: Specific vaginal bacteria are associated with incident Trichomonas vaginalis infection in women. Olamide Jarrett (10′) TALK 1: An analysis of the efficacy of clinically relevant new dual drug combinations for treatment of multi- and extensively-drug resistant Neisseria gonorrhoeae.Vikram Singh (10′) (scholarship recipient) TALK 1: Investigating the interaction of the stealth pathogen and causative agent of syphilis, Treponema pallidum,with human platelets. Brigette Church (10′)
  Engaging youth in innovative technologies across the HIV prevention and care continuum: A review of the iTech portfolio. Lisa Hightow-Weidman, University of North Carolina, USA (15′) A path forward for a syphilis vaccine. Sheila Lukehart, University of Washington, USA (15′) Towards triple elimination of mother to child transmission of HIV, syphilis and hepatitis B. Massimo Ghinidelli, Pan American Health Organization (15′) TALK 2: Effects of over-the-counter lactic acid-containing vaginal douching products on the vaginal microbiota. Charlotte Van Der Veer (10′) TALK 2: Pharyngeal gonococcal infection: spontaneous clearance and persistence after treatment. Maarten Schim van der Loeff (10′) TALK 2:Initial interactions of Herpes Simplex Virus with human skin dendritic cells. Tony Cunningham  (10′)
  The role of STI testing in a mobile prevention app focused on HIV prevention for MSM. Patrick Sullivan, Emory University, USA (15′) Progress on a herpes simplex virus vaccine. Anna Wald, University of Washington, USA (15′) Asia Pacific regional framework for triple elimination of mother-to-child transmission of HIV, syphilis and hepatitis B – opportunities for synergies. Naoko Ishikawa, Western Pacific Region, World Health Organization (15′) TALK 3: Uptake and acceptability of contraceptive vaginal ring among women with bacterial vaginosis in Kenya. Kenneth Ngure (10′) (scholarship recipient) TALK 3:A Phase II, randomized, study in adult subjects evaluating the efficacy, safety, and tolerability of single doses of Gepotidacin (GSK 2140944) for treatment of uncomplicated urogenital gonorrhea. Caroline R Perry (10′) TALK 3: Development of a human urethral equivalent to study Chlamydia trachomatisinvasion. Bart Versteeg (10′)
    Progress towards a Chlamydia trachomatis STI vaccine. (15′) Shortages of benzathine penicillin: identifying opportunities to ensure stable and adequate supply. Frederic Seghers, Clinton Health Access Initiative (15′) TALK 4: The Netherlands Chlamydia cohort study (NECCST): risks of long-term complications following Chlamydia trachomatis infections in women. Bernice Hoenderboom (10′) TALK 4: Does high-level azithromycin resistance emerge from low-level resistance in Neisseria gonorrhoeae? Michelle Cole (10′) TALK 4:Higher levels of a cytotoxic protein, vaginolysin, in Lactobacillus-deficient community state types in the vaginal mucosa. Rebecca Brotman (10′)
  There’s an app for that: What role do geospatial networking apps play in STI outbreaks? Hamish Mohammed, National Infection Service, Public Health England, London UK (15′) The global STI vaccine roadmap: moving forward. Sami Gottlieb, World Health Organization (10′) Role of rapid tests in the elimination of congenital syphilis. Adele Schwartz-Benzaken, Brazilian Ministry of Health (15′) TALK 5: A psychosocial evaluation of the Zika Virus: U.S. pregnant women’s knowledge and attitudes about prevention. Susan L. Rosenthal (10′) TALK 5: What role does importation play in the spread of antimicrobial resistant Neisseria gonorrhoeaein the UK? Associations between antimicrobial resistant strains and recent sex abroad. Katy Town (10′) TALK 5: Analysis of the Treponema pallidumproteome for evidence of host protein mimicry; identification of a mechanism for bacterial persistence and establishment of latency during syphilis infection? Simon Houston (10′)
        TALK 6: The “Male Partner in the Prenatal Care Strategy” as a relevant option to reduce congenital syphilis. Geraldo Duarte (10′) TALK 6: The impact of a rapid genotypic Neisseria gonorrhoeaeassay on targeted Ciprofloxacin therapy. Jeffrey Klausner (10′) TALK 6: The urethral microbiota in nongonococcal uretritis. Sujatha Srinivasan (10′)
          TALK 7: The efficacy and safety of gentamicin for the treatment of genital, pharyngeal and rectal gonorrhoea: a randomised controlled trial. Jonathan Ross (10′)  
3:30 – 4:15 COFFEE BREAK          
  Chairs: Jacky Jennings & Basil Donovan          
4:15-4:45 PLENARY 4: Refugees and HIV/STI risks and responses. Paul Spiegel, Johns Hopkins Bloomberg School of Public Health, USA (30′)          
4:45-5:15 PLENARY 5: Know your status: How we can harness the power of dating apps to educate and empower around HIV/STI prevention. Alex Garner, Hornet Gay Social Networking App, USA (30′)          
5:15-5:30 Evening plenary question period          
  Chairs: Patrick Sullivan & Raj Patel          
5:30-6:00 Debate: Sexual education starting at age 4: is it too early? Mark Schuster, Boston Children’s Hospital, USA. Dennis Fortenberry, Indiana University, USA          
6:00-7:00 POSTER VIEWING          
7:00-8:30 WHO-NIH-CDC Organized Session: Emergence of new STI: facts and challenges
Chairs: Nathalie Broutet and Kyle Bernstein
1- Review of sexual transmission of Ebola and Zika virus and impact on the epidemics – Nathalie Broutet, WHO (10′)

2- How to explore sexual transmission?
a. Sexual transmission framework – Nicola Low, University of Bern (12′)
b. A study in Brazil – Ana Bispo, Fiocruz Brazil (12′)
c. Summary of sexual transmission of Ebola – Kyle Bernstein, CDC (12′)

3- Health messaging and communication – Rachel Kachur, CDC (12′)

4- Considerations for implementation of sexual transmission framework – Carolyn Deal, NIH (12′)

TUESDAY – July 11
7:00 – 8:30     Closed session: WHO-NIH STI Vaccine Initiative planning meeting      
7:15-8:15 Clinical Case Series Chairs: Bradley Stoner & Keith Radcliffe          
  Neurosyphilis in an HIV-infected patient, Helena Biasizzo (scholarship recipient)          
  Buschke-Löwenstein tumor in association with HPV types 6, 11, Natasha Tsekova Traykovich (scholarship recipient)          
  Chairs: Angelica Espinosa Miranda & King K. Holmes          
8:45:-9:15 PLENARY 6: Biomarkers for HIV risk using systems biology tools. Douglas Kwon, Harvard Medical School, USA (30′)          
9:15-9:45 PLENARY 7: Zika virus: Vectorial vs. sexual transmission, what we know and why it matters. Flavio Codeco Coelho, Fundação Getulio Vagas, Rio de Janeiro, Brazil (30′)          
9:45-10:15 PLENARY 8: Surveillance of neglected STIs, the evolving landscape. Gwenda Hughes, National Centre for Infectious Disease Surveillance and Control at Public Health, UK (30′)          
10:15-10:30 Morning plenary question period          
10:30-11:15 COFFEE BREAK          
11:15-12:30 SYMPOSIUM 7: Noncondom-based interventions for STI control Chairs: Christopher Fairley & Mariangela Freitas da Silveira SYMPOSIUM 8: The dual epidemics of STIs and HIV in women and girls Chairs: Christine Johnston & Michel Alary SYMPOSIUM 9: Evolution and global spread of resistance in STIs Chairs: Jo-Anne Dillon & Jorgen Jensen ORAL PRESENTATION SESSION 7 STI/HIV risk reduction Chairs: Chavalit Mangkalaviraj & Jami Leichliter ORAL PRESENTATION SESSION 8 STIs/HIV amongst populations Chairs: Patricia Kissinger & Edilbert Pelegrini Nahn Junior ORAL PRESENTATION SESSION 9 PrEP Chairs: Meredith Temple-Smith & Kaushal Verma
  Does doxycycline prophylaxis have a future? Jeffrey Klausner, University of California Los Angeles, USA (20′) Investigating combination HIV prevention: isolated interventions or a complex system? Gina Brown, National Institutes of Health, USA (20′) Evolution and global spread of resistance in Neisseria gonorrhoeae. Magnus Unemo, Örebro University Hospital, Sweden (20′) TALK 1: Novel use of venue-specific codes to track impact of a campaign to increase awareness and use of an online HIV/STI testing service (getcheckedonline) among gay and bisexual men in Vancouver, Canada. Mark Gilbert (10′) TALK 1: A national survey of Canadians on HPV: comparing knowledge, barriers and preventive practices of physicians to those of consumers. Marc Steben (10′) TALK 1: Awareness and interest in pre-exposure prophylaxis (PrEP) among patients receiving services at a public sexually transmitted diseases (STD) clinic in a high prevalence urban setting. Luke Johnsen (10′)
        TALK 2:Physicians’ willingness to prescribe PreP: results of an online survey in Belgium. Thijs Reyniers (10′) TALK 2: Incidence and predictors of urogenital C. trachomatisand N. gonorrhoeaeamong men who have sex with men in Kisumu, Kenya. Supriya Mehta (10′) TALK 2:Feasibility, acceptability and potential role of PrEP in combination HIV prevention for MSM and transwomen in Peru: Results of a mixed-methods study. Carlos F Cáceres (10′)
  Vaccines for STI prevention in men who have sex with men: immunisation thresholds, current status and future prospects. David Regan, The University of New South Wales, Australia (20′) The role of the vaginal microbiome in STI/HIV prevention. Jennifer Balkus, University of Washington, USA (20′) Evolution and global spread of resistance in Mycoplasma genitalium. Catriona Bradshaw, Monash University, Australia (20′) TALK 3: Heads in the sand? STI risk perception in the British population poorly relates to sexual behaviour: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Anne Johnson (10′) TALK 3: Barriers and facilitators to engagement in the HIV prevention cascade among lesbian, gay, bisexual, and transgender persons in Swaziland. Carmen Logie (10′) Talk 3:Changes in sexual risk behaviour among daily PrEP users after 6 months of use in the Amsterdam PrEP Project. Anna van Laarhoven (10′)
        TALK 4:Challenges of improving reproductive health literacy: learnings from practitioners caring for humanitarian entrants from Burma. Amita Tuteja (10′) TALK 4: Psychosocial determinants of sexual practices among women using heroin and other drugs: a systematic literature review. Laura Medina-Perucha (10′) (scholarship recipient) TALK 4: Assessment of clinic and community recruited young African American women for PrEP eligibility in Atlanta, Georgia. Riley Steiner (10′)
  Risk compensation in men who have sex with men in the era of biomedical (non-condom) interventions. Henry de Vries, University of Amsterdam, Netherlands (20′) Investigating the importance of integrated interventions to advance the sexual and reproductive health of women and girls at risk of STIs, including HIV. Manjulaa Narasimhan, World Health Organization (20″) Are we treating Chlamydia adequately? Basil Donovan, The University of New South Wales, Australia (20′) TALK 5: Predictors of responsiveness among American Indian adolescents to a community-based HIV risk-reduction intervention. Anne Rompalo  (10′) TALK 5: Crossing the bridge: exploring sexual risk profiles of men who have sex with men attending a sex on premises venue and a public sexual health clinic for STI screening in Sydney, Australia. Catriona Ooi (10′) TALK 5: PrEP awareness, eligibility, and acceptability among heterosexuals recruited from community-based HIV testing sites. Alexis M Roth (10′)
        TALK 6: Exploring the role of sex and sexual experience in predicting American Indian adolescent condom use intention using protection motivation theory. Anne Rompalo (10′)   TALK 6: Integration of PrEP in an academic adolescent clinic & impact of PrEP use on Sexually Transmitted Infection (STI) rates. Renata Sanders (10′)
            TALK 7: Knowledge, attitudes, and beliefs about HIV pre-exposure prophylaxis among U.S. army health care providers. Eric Garges (10′)
12:30-2:00 LUNCH          
12:30-2:00 ASTDA AWARD LUNCHEON          
12:30-2:00 POSTER VIEWING          
2:00-3:30 SYMPOSIUM 10: Tackling antimicrobial resistance in Neisseria gonorrhoeae: a need for a comprehensive and collaborative approach Chairs: Ranmini Kularatne & Edward Hook III SYMPOSIUM 11: Mycoplasma genitalium amongst the clinical, microbiology and public health communities Chairs: Angelica Stary & Jonathan Ross SYMPOSIUM 12: STIs in MSM; What will be new in the future? Chairs: Henry de Vries & Paulo Cesar Giraldo ORAL PRESENTATION SESSION 10 Novel technologies for molecular analysis and diagnosis Chairs: Sheila Lukehart & Jose Eleuterio Junior ORAL PRESENTATION SESSION 11 STI diagnosis and clinical observations Chairs: David Templeton & Anna Wald ORAL PRESENTATION SESSION 12 Antimicrobial resistance Chairs: Michelle Cole & Ivo Castelo Branco
  Linking control and impact of AMR in N. gonorrhoeae to the global antimicrobial action plan. Pilar Ramon-Pardo, Pan American Health Organization. (15′) Antimicrobial treatment of Mycoplasma genitalium. Jørgen Skov Jensen, Statens Serum Institut, Copenhagen, Denmark (15′) Understanding transmission dynamics – allows new interventions. Christopher K Fairley, Monash University and Melbourne Sexual Health Centre, Australia (15′) Talk 1:High amounts of viable Chlamydia trachomatisin anorectal positive women revealed by viability-PCR. Kevin Janssen (10′) TALK 1: Decline in genital shedding in the year after first clinical episode genital Herpes Simplex Virus type 1. Christine Johnston (10′) TALK 1: Establishing a Department of Defense (DoD) gonococcal resistance surveillance effort, reference laboratory and repository from a population of at-risk United States DoD beneficiaries. Grace Macalino (10′)
        TALK 2: A performance evaluation of the atlas genetics LTD IO® system: a novel and rapid point-of-care in vitro diagnostic test for Chlamydia trachomatis. Emma Cousins (10′) TALK 2: Repeat syphilis is associated with an altered immune profile. Chris Kenyon (10′) TALK 2:Co-infection and macrolide antimicrobial resistance (AMR) of Mycoplasma genitaliumwith Neisseria gonorrhoeaeand Chlamydia trachomatis,in females, heterosexual males, and men-who-have-sex-with-men. Claire Broad (10′)
  Monitoring antimicrobial resistance in N. gonorrhoeae in Latin America. Patricia Galarza, Administracion Nacional de Laboratorios, Argentina (15′) Current status of diagnostic assays for Mycoplasma genitalium. Charlotte Gaydos, Johns Hopkins University, USA (15′) Scanning the horizon: anticipated and threatened STI outbreaks within MSM communities. David Lewis, Western Sydney Sexual Health Centre and University of Sydney, Australia (15′) TALK 3: Prospective clinical evaluation of the Aptima Mycoplasma genitalium assay (CE-IVD) in various specimens from symptomatic and asymptomatic patients in France. Cecile Bebear (10′) TALK 3: Extreme heterogeneity in vaginal microbial kinetics within and across women. Joshua Schiffer (10′) TALK 3: The emergence and spread of antimicrobial resistant Neisseria gonorrhoeaein HIV positive men who have sex with men. Katy Town (10′)
        Talk 4: Concordance between random catch urine and mid-vaginal microbiota. Rebecca Brotman (10′) TALK 4: Clinician-taken extra-genital samples for gonorrhoea and chlamydia in women and MSM compared with self-taken samples analysed separately and self-taken pooled samples. Janet Wilson (10′) Talk 4: Prevalence of Mycoplasma genitaliumand macrolide resistance in asymptomatic men who have sex with men (MSM) attending a sexual health centre. Tim Read (10′)
  Reducing N. gonorrhoeae infection: Appropriate treatment and new drugs in the pipeline and gonorrhoea vaccines. Carolyn Deal, National Institutes of Health, USA (15′) Clinical management of M. genitalium. Lisa Manhart, University of Washington, USA (15′) Sexual identities and HIV/STI prevention among MSM. Carlos Caceres, Universidad Peruana Cayetano Heredia, Peru (15′) TALK 5: Testing of BD MAX™ vaginal panel residual specimens using the BD MAX™ CT/GC/TV assay. Barbara Van Der Pol (10′) TALK 5: Comparative effectiveness of single and dual rapid diagnostic tests for syphilis and HIV in antenatal care services in Colombia. Hernando G Gaitan Duarte (10′) TALK 5: Factors associated with antimicrobial resistant gonorrhoea infections in men who have sex with men: case-control study. Nicola Low (10′)
        TALK 6: Clearance of Mycoplasma genitalium and Trichomonas vaginalis among adolescents and young adults with pelvic inflammatory disease: results from the Tech-N Study. Maria Trent (10′) TALK 6: Express testing in urban STD clinics has no impact on gonorrhea treatment completion rates compared to clinical examination and testing among patients not receiving presumptive treatment. Christina Schumacher (10′)  
  Identifying new technologies and approaches for detecting AMR in low and middle income countries. Jo-Anne Dillon, University of Saskatchewan, Canada (15′) Treatment of Mycoplasma genitalium from a public health perspective. Newton Sergio de Carvalho. Federal University of Paraná, Brazil (15′) Chemsex, sexual behavior and HIV/STI prevention among MSM. Mark Pakianathan, St. George’s University Hosptials, UK (15′)      
3:30-4:00 COFFEE BREAK          
  Chairs: Sami Gottlieb & Adele Schwartz-Benzaken          
4:00-4:30 PLENARY 9: A new focus for social and behavioral research in the era of biomedical advances in STI and HIV treatment and prevention. Patricia Dittus, Centers for Disease Control and Prevention, USA (30′)          
4:30-5:00 PLENARY 10: Lessons learned from the Zika epidemic: reproductive justice as a human right. Debora Diniz. University of Brasília (Brazil) and Anis – Instute of Bioethics. (30′)          
5:00-5:20 Evening plenary question period          
  Chairs: Jeffrey Klausner & Valeria Saraceni          
5:20-5:50 Debate: Global, national and local public health agencies should make PrEP available on-demand: Matthew Golden, University of Washington, USA; Beatriz Grinsztejn, Oswaldo Cruz Foundation, Brazil          
6:00-7:00 POSTER VIEWING          
07:30 GALA DINNER          
7:15-8:15 Clinical Case Series Chairs: Freddy Tinajeros & Mariangela Freitas da Silveira          
  Exotic Mycobacteria in a patient with HIV immunosuppression, Marcos Davi Gomes de Sousa (scholarship recipient)          
  Penile verrucous squamous cell carcinoma in a patient with non-Hodgkin lymphoma, Natasha Tsekova Traykovich (scholarship recipient)          
  Chairs: Dennis Fortenberry & Caroline Cameron          
8:45:-9:15 PLENARY 11: TO BE OR NOT TO BE. Civil society and HIV: Why not the other STIs? Fabio Mesquita, World Health Organization (30′)          
9:15-9:45 PLENARY 12: The future of anal cancer prevention. Andrew Grulich. The University of New South Wales, Australia (30′)          
9:45-10:00 Morning plenary question period          
10:00-10:45 COFFEE BREAK          
10:45-12:00 SYMPOSIUM 13: Modifying the vaginal microbiome to impact STI/HIV risk Chairs: Marcia Hobbs & Valdir Monteiro Pinto SYMPOSIUM 14: For authors and editors – making publication work for you and your patients Chairs: Mauro Romero Passos & Nicola Low ORAL PRESENTATION SESSION 13 Biomedical and systems biology Chairs: Tony Cunningham & Nicole Scangarella-Oman ORAL PRESENTATION SESSION 14 STI/HIV epidemiology and prevention Chairs: Maarten Schim van der Loeff & Gail Bolan ORAL PRESENTATION SESSION 15 STI/HIV testing and management Chairs: Anne Johnson & Imtyaz Ahmed-Jushuf ORAL PRESENTATION SESSION 16 HIV Chairs: Miguel Tilli & Susan Rosenthal
  The vaginal microbiome and STIs. Janet Wilson, Leeds Teaching Hospitals NHS Trust, UK (20′) Introduction – Nicola Low, Deputy Editor, Sexually Transmitted Infections and Specialty Consulting Editor, PLOS Medicine TALK 1: Survey of antimicrobial resistance in clinical Neisseria gonorrhoeaeisolated over four years in Nairobi – Kenya. Meshack Juma Omolo TALK 1: Risk of HIV following repeat sexually transmissible infections among men who have sex with men in Victoria, Australia. Brendan Harney (10′) TALK 1: Examining the role of location in STI prevention among men who have sex with men using mobile applications. Joshua Rosenberger (10′) TALK 1: Evaluating the present and projecting the future: national network of young people living with HIV/AIDS – RJ: life stories. Regina Célia de Oliveira Bueno (10′)
    Getting to know how a major general infectious diseases journal works – Marco De Ambrogi, Senior editor, Lancet Infectious Diseases (15’) TALK 2: Molecular epidemiology in relation to azithromycin resistance in Neisseria gonorrhoeae isolates from Amsterdam, the Netherlands, between 2008 and 2015 – a case-control study. Alje P Van Dam TALK 2: High incidence of non-urethral Neisseria gonorrhoeaeand Chlamydia trachomatisinfections among men who have sex with men and transgender women in Lima, Peru. Jeffrey Klausner (10′) TALK 2: Findings from the national online HIV self-sampling service in England: A nation-wide joined approach to increase HIV testing access among most at-risk populations. Luis Guerra (10′) TALK 2: Loss to follow-up and patient self-discontinuation of HIV pre-exposure prophylaxis (PreP) in an STD clinic-based PrEP program with adherence support. Julie Dombrowski (10′)
  Characteristics of vaginal microbicides in women with bacterial vaginosis. Sharon Hillier, University of Pittsburgh, USA (20′) A new kid on the block: Insight for authors – Christopher Fairley, co-Editor-in-chief, Sexual Health (15’) TALK 3: Vaccine development to combat antimicrobial resistant gonorrhoea. Kate L Seib TALK 3: How war and risky sexual behaviours shape the Ukrainian HIV epidemic: a phylogeographic analysis. Tetyana I Vasylyeva (10′) (scholarship recipient) TALK 3: Cost-effectiveness of antimicrobial resistance point-of-care testing for optimising the treatment of gonorrhoea. Emma Harding-Esch (10′) TALK 3: Privacy vs. health rights – should hospitals disclose HIV status with patients’ partners? An analysis of perspectives on social networking in China. Li Du (10′) (scholarship recipient)
    Trends and challenges of a scientific journal in America Latina – Carlos Brites, former editor, The Brazilian Journal of Infectious Diseases (15’) TALK 4: Multiple cytokine gene expression detected after HPV vaccination. Ana Paula Ferreira Costa TALK 4: Oropharyngeal transmission of Neisseria gonorrhoeaeamong men who have sex with men and potential impacts of mouthwash. Lei Zhang (10′) TALK 4: Investigating selection bias: cross-sample comparison of gay and bisexual men concurrently recruited from an STI clinic, sex-seeking apps, and a pride event in British Columbia, Canada. Travis Salway (10′) TALK 4:Willingness of young persons in South-Western Nigeria to participate in early HIV vaccine trials. Usman Saheed Opeyemi (10′) (scholarship recipient)
  Microbiome composition and function in the female genital tract. José Eleuterio Junior, Universidade Federal do Ceará, Brazil (20′) A call for research papers on the prevention, diagnosis and treatment of sexually transmitted infections – Larry Peiperl, Editor-in-chief, PLOS Medicine (5′) TALK 5: Understanding health facility barriers to the implementation of Option B+ guidelines in an urban hospital in Ghana: a qualitative analysis of views and perspectives of health providers. Alexander Laar (scholarship recipient) TALK 5: Continuous decline of HIV prevalence and incidence among female sex workers in Benin over 22 years of targeted intervention, but resurgence of gonorrhea in the context of inadequate treatment policies. Michel Alary (10′) TALK 5: Awareness and interest in pre-exposure prophylaxis (PrEP) among young men attending a public sexually transmitted diseases (STD) clinic in a high prevalence urban setting. Luke Johnsen (10′)  
    Discussant – Jackie Cassell, Editor-in-chief, Sexually Transmitted Infections (5’)   TALK 6: Sexual transmission of flaviviruses – a living systematic review. Michel Counotte (10′) TALK 6:  Differences in reported testing barriers between clients of an online STI testing service ( and a provincial STI clinic in Vancouver, Canada. Mark Gilbert (10′)  
    Questions from the audience – Nicola Low, Mauro Romero Passos (Editor-in-chief, Jornal Brasileiro de DST), William Miller (Editor-in-chief, Sexually Transmitted Diseases), moderators (20’)        
12:00-1:30 LUNCH          
12:00-1:30 POSTER VIEWING          
1:30-3:00 SYMPOSIUM 15: Program science applied to the Latin America National program: country specific results? Chairs: Sevgi Aral & Cesar Carcamo Cavagnaro SYMPOSIUM 16: Pre-Exposure Prophylaxis (PrEP) of HIV: impact on sexually transmitted infections (STIs) and lessons learned from real-life implementation. Chairs: Tatianna Alencar & Carlos Cáceres   ORAL PRESENTATION SESSION 17 Country-specific investigations Chairs: Bradley Stoner & Ina Park LATE BREAKERS Chairs: Nicola Low & Janet Wilson  
        TALK 1: Prevalence of Neisseria gonorrhoeaeand Chlamydia trachomatis infections in different anatomic sites among men who have sex with men: Results of 380 MSM who attended a STD clinic in Guangzhou, China. Ligang Yang (10′) TALK 1: Insights into the evolution of syphilis spirochetes within at-risk populations: Sequence variation of outer membrane protein beta-barrel domains in clinical samples. Justin Radolf (10′)  
  TALK 1: Prevention of mother-to-child transmission of HIV in Peru, 2015-2016. Byelca Huaman, Ministerio de Salud, Peru (15′) New WHO implementation guidance on use of PrEP for HIV prevention. Ioannis Hodges-Mameletzis, World Health Organization (15′)   TALK 2: Population effectiveness of human papillomavirus vaccination against anogenital warts among female enrollees in private health plans in the United States, 2006-2014. Elaine W. Flagg (10′) TALK 2: What is the strength of evidence for HIV and HPV interactions? Results from systematic reviews and meta-analyses of longitudinal studies. Minttu Ronn (10′)  
    Panel on PrEP of HIV: impact on STIs and lessons learned from real-life implementation   TALK 3: Pre-exposure prophylaxis (PrEP) eligibility and barriers to uptake among persons who inject drugs recruited from a Syringe Exchange Program (SEP). Alexis M Roth    
  TALK 2: Analysis of interventions for the prevention of mother-to-child transmission of HIV in Colombia. Jennifer Ortiz, Ministry of Health and Social Protection of Colombia, Colombia (15′) The Latin America Experience in PrEP Implementation. Beatriz Grinsztejn, FIOCRUZ Rio de Janeiro, Brazil (15′)   TALK 4: The perils of forced sex within marriage in India: Exploring the psychosexual aspect of sexual behaviours and attitude among young married men. Atreyee Sinha (10′) (scholarship recipient) TALK 3: Improved outcomes following resistance-guided treatment of Mycoplasma genitalium infection. Tim Read (10′)  
    The Australian Experience in PrEP Implementation. Andrew Grulich, The University of New South Wales, Australia (15′)   TALK 5: Positive attitudes toward undergoing voluntary male medical circumcision among a Malawian cohort. Alison Norris (10′) TALK 4: Neisseria meningitidis carriage among men who have sex with men – New York City, 2016-2017. Preeti Pathela (10′)  
  TALK 3: Epidemiology of HIV outcomes and virologic failure in a clinic in the Ngobe-Buglé region, Panama. December 2016. Ana Belen Arauz. Hospital Santo Tomás, Panamá (15′) The African experience in PrEP Implementation. Hasina Subedar, National Department of Health, Pretoria, South Africa (15′)     TALK 5: Australian national surveillance of juvenile onset recurrent respiratory papillomatosis: declining incidence post quadrivalent HPV vaccination. Suzanne Garland (10′)  
    The Thailand experience in PrEP Implementation. Midnight Poonkasetwattana, APCOM (15′)        
  TALK 4: Kuskaya program science project overview. Cesar Carcamo Cavagnaro, Universidad Peruana Cayetano Heredia, Peru (20′) Launch of the PrEP Fiocruz-UNITAID project (10’)        
3:00-3:30 Coffee Break          
3:30-4:00 CLOSING CEREMONY REMARKS